3 October 2011
Beta-blockers could end up being used as a breast cancer treatment, thanks to positive early results from a British-led research programme.
Scientists from Nottingham University Hospitals NHS Trust have worked alongside experts from Belfast and Germany to investigate the potential for beta-blockers to prevent the spread of the disease following cancer diagnosis.
While the drugs are routinely used to address high blood pressure and anxiety problems, people with a breast cancer diagnosis who take them during regular treatment appear to be less likely to suffer from a recurrence.
Dr Des Powe, a Cancer Research UK-funded scientist from Nottingham, who is collaborating on the new study, said stopping the spread of cancer following diagnosis is a vital part of treatment and extends people's life expectancy.
He noted: "This study will be sufficiently large to determine whether we should progress to clinical trials and identify which type of beta-blockers have the strongest effect."
The announcement comes as Breast Cancer Awareness Month gets underway, incorporating a variety of headline-grabbing events to boost the profile of the condition, including a show at London Fashion Week.
Posted by Edward Bartel
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.